These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 38805035)

  • 1. Decoding antimicrobial resistance: unraveling molecular mechanisms and targeted strategies.
    Singh G; Rana A; Smriti
    Arch Microbiol; 2024 May; 206(6):280. PubMed ID: 38805035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial peptides as promising antibiotic adjuvants to combat drug-resistant pathogens.
    Chen C; Shi J; Wang D; Kong P; Wang Z; Liu Y
    Crit Rev Microbiol; 2024 May; 50(3):267-284. PubMed ID: 36890767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies to Overcome Antimicrobial Resistance in Nosocomial Infections, A Review and Update.
    Bakhtiyari N; Farajnia S; Ghasemali S; Farajnia S; Pormohammad A; Saeidvafa S
    Infect Disord Drug Targets; 2024; 24(6):e260124226226. PubMed ID: 38284691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic pathways and antimicrobial peptide resistance in bacteria.
    Elbediwi M; Rolff J
    J Antimicrob Chemother; 2024 Jul; 79(7):1473-1483. PubMed ID: 38742645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineered CRISPR-Cas systems for the detection and control of antibiotic-resistant infections.
    Wu Y; Battalapalli D; Hakeem MJ; Selamneni V; Zhang P; Draz MS; Ruan Z
    J Nanobiotechnology; 2021 Dec; 19(1):401. PubMed ID: 34863214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR-Cas System: A New Dawn to Combat Antibiotic Resistance.
    Rafiq MS; Shabbir MA; Raza A; Irshad S; Asghar A; Maan MK; Gondal MA; Hao H
    BioDrugs; 2024 May; 38(3):387-404. PubMed ID: 38605260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR-cas system: biological function in microbes and its use to treat antimicrobial resistant pathogens.
    Shabbir MAB; Shabbir MZ; Wu Q; Mahmood S; Sajid A; Maan MK; Ahmed S; Naveed U; Hao H; Yuan Z
    Ann Clin Microbiol Antimicrob; 2019 Jul; 18(1):21. PubMed ID: 31277669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR-Cas-Based Antimicrobials: Design, Challenges, and Bacterial Mechanisms of Resistance.
    Mayorga-Ramos A; Zúñiga-Miranda J; Carrera-Pacheco SE; Barba-Ostria C; Guamán LP
    ACS Infect Dis; 2023 Jul; 9(7):1283-1302. PubMed ID: 37347230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial Peptides Therapy: An Emerging Alternative for Treating Drug-Resistant Bacteria.
    Mba IE; Nweze EI
    Yale J Biol Med; 2022 Dec; 95(4):445-463. PubMed ID: 36568838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial peptides for combating drug-resistant bacterial infections.
    Xuan J; Feng W; Wang J; Wang R; Zhang B; Bo L; Chen ZS; Yang H; Sun L
    Drug Resist Updat; 2023 May; 68():100954. PubMed ID: 36905712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innovative Delivery System Combining CRISPR-Cas12f for Combatting Antimicrobial Resistance in Gram-Negative Bacteria.
    Long TF; Zhou SY; Huang ZL; Li G; Zhong Q; Zhang XJ; Li YY; Chen CP; Xia LJ; Wei R; Wan L; Gao A; Ren H; Liao XP; Liu YH; Chen L; Sun J
    ACS Synth Biol; 2024 Jun; 13(6):1831-1841. PubMed ID: 38863339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticle-based local antimicrobial drug delivery.
    Gao W; Chen Y; Zhang Y; Zhang Q; Zhang L
    Adv Drug Deliv Rev; 2018 Mar; 127():46-57. PubMed ID: 28939377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combating Antimicrobial Resistance by Employing Antimicrobial Peptides: Immunomodulators and Therapeutic Agents against Infectious Diseases.
    Mehraj I; Hamid A; Gani U; Iralu N; Manzoor T; Saleem Bhat S
    ACS Appl Bio Mater; 2024 Apr; 7(4):2023-2035. PubMed ID: 38533844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in gene-editing approaches for tackling antibiotic resistance threats: a review.
    Al-Fadhli AH; Jamal WY
    Front Cell Infect Microbiol; 2024; 14():1410115. PubMed ID: 38994001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial peptides: Opportunities and challenges in overcoming resistance.
    Bucataru C; Ciobanasu C
    Microbiol Res; 2024 Jun; 286():127822. PubMed ID: 38986182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combating antimicrobial resistance: antimicrobial stewardship program in Taiwan.
    Tseng SH; Lee CM; Lin TY; Chang SC; Chuang YC; Yen MY; Hwang KP; Leu HS; Yen CC; Chang FY
    J Microbiol Immunol Infect; 2012 Apr; 45(2):79-89. PubMed ID: 22483434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial Peptides: the Achilles' Heel of Antibiotic Resistance?
    Lewies A; Du Plessis LH; Wentzel JF
    Probiotics Antimicrob Proteins; 2019 Jun; 11(2):370-381. PubMed ID: 30229514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergism between Host Defence Peptides and Antibiotics Against Bacterial Infections.
    Li J; Fernández-Millán P; Boix E
    Curr Top Med Chem; 2020; 20(14):1238-1263. PubMed ID: 32124698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of vaccines on antimicrobial resistance.
    Buchy P; Ascioglu S; Buisson Y; Datta S; Nissen M; Tambyah PA; Vong S
    Int J Infect Dis; 2020 Jan; 90():188-196. PubMed ID: 31622674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and challenges of antimicrobial peptide delivery strategies in bacterial therapy: A review.
    Yao L; Liu Q; Lei Z; Sun T
    Int J Biol Macromol; 2023 Dec; 253(Pt 3):126819. PubMed ID: 37709236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.